
Compound 23
CAS No. 2417296-84-3
Compound 23( —— )
Catalog No. M24115 CAS No. 2417296-84-3
Compound 23 selectively induces degradation of BRAF-V600E but not wildtype BRAF.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 479 | In Stock |
![]() ![]() |
10MG | 627 | In Stock |
![]() ![]() |
25MG | 1026 | In Stock |
![]() ![]() |
100MG | Get Quote | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameCompound 23
-
NoteResearch use only, not for human use.
-
Brief DescriptionCompound 23 selectively induces degradation of BRAF-V600E but not wildtype BRAF.
-
DescriptionCompound 23 selectively induces degradation of BRAF-V600E but not wildtype BRAF.
-
In VitroPROTAC BRAF-V600E degrader-1 (compound 23) (1 nM-10 μM; 72 h) inhibits the cell viability of A375 and HT-29.PROTAC BRAF-V600E degrader-1 (1-1000 nM; 16 h or 0-24 h) inhibits p-ERK and BRAF-V600E protein in A375 cells. Cell Viability Assay Cell Line:A375 and HT-29 Concentration:1 nM-10 μM Incubation Time:72 h Result:Inhibited the cell viability of A375 and HT-29 with IC50s of 46.5 nM and 51 nM.Western Blot Analysis Cell Line:A375 Concentration:1, 4, 12, 37, 111, 333 and 1000 nM Incubation Time:16 h or 0-24 h Result:Induced the reduction in the phosphorylation of ERK.Inhibited p-ERK and BRAF-V600E in a dose- and time-dependent manner.
-
In Vivo——
-
Synonyms——
-
PathwayMAPK/ERK Signaling
-
TargetRaf
-
RecptorB-Raf (V600E)
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2417296-84-3
-
Formula Weight1001.07
-
Molecular FormulaC48H54F2N10O10S
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESCCCS(=O)(NC1=CC=C(F)C(N2C=C(C3=CN=CN=C3)C4=NC(N(C5CCN(C(CCOCCOCCOCCNC6=CC=CC(C(N7C(CC8)C(NC8=O)=O)=O)=C6C7=O)=O)CC5)C)=CC=C42)=C1F)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Han X R , Chen L , Wei Y , et al. Discovery of Selective Small Molecule Degraders of BRAF-V600E[J]. Journal of Medicinal Chemistry, 2020, XXXX(XXX).
molnova catalog



related products
-
Sorafenib-d3
Sorafenib-d3 is a deuterium-labeled Sorafenib which is a multikinase inhibitor(IC50s: 6 nM, 20 nM, and 22 nM for Raf-1, B-Raf, and VEGFR-3, respectively).
-
Sorafenib
A potent, orally available Raf inhibitor with IC50 of 6, 22, and 38 nM for Raf-1, wt Braf, and BRaf V599E, respectively.
-
Lonafarnib
Lonafarnib is an orally bioavailable FPTase inhibitor for H-ras, K-ras-4B and N-ras with IC50 of 1.9 nM, 5.2 nM and 2.8 nM, respectively. Phase 3.